Article Details
Retrieved on: 2021-11-27 18:00:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Online ahead of print. ABSTRACT. BACKGROUND AND OBJECTIVES: The use of COVID-19 convalescent plasma (CCP) has been approved by the FDA. We assessed ...
Article found on: www.docwirenews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here